Robert Mestayer Mallery, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pseudotumor Cerebri | 5 | 2019 | 108 | 2.300 |
Why?
|
Papilledema | 5 | 2019 | 130 | 1.890 |
Why?
|
Fixation, Ocular | 2 | 2018 | 242 | 1.000 |
Why?
|
Optic Nerve | 5 | 2021 | 572 | 0.970 |
Why?
|
Intracranial Hypertension | 2 | 2019 | 193 | 0.960 |
Why?
|
Tomography, Optical Coherence | 3 | 2018 | 2917 | 0.690 |
Why?
|
Sella Turcica | 1 | 2018 | 118 | 0.600 |
Why?
|
Pituitary Diseases | 1 | 2018 | 135 | 0.570 |
Why?
|
Optic Nerve Diseases | 2 | 2021 | 342 | 0.560 |
Why?
|
Optic Nerve Injuries | 1 | 2018 | 150 | 0.540 |
Why?
|
Ocular Motility Disorders | 1 | 2018 | 144 | 0.530 |
Why?
|
Vision Disorders | 2 | 2014 | 1088 | 0.530 |
Why?
|
Retinal Ganglion Cells | 2 | 2018 | 811 | 0.450 |
Why?
|
Blindness | 1 | 2018 | 584 | 0.440 |
Why?
|
Eye Diseases | 1 | 2019 | 654 | 0.430 |
Why?
|
Visual Acuity | 3 | 2018 | 2672 | 0.420 |
Why?
|
Decompression, Surgical | 1 | 2018 | 608 | 0.410 |
Why?
|
Nerve Fibers | 1 | 2016 | 708 | 0.410 |
Why?
|
Abducens Nerve Diseases | 1 | 2012 | 44 | 0.410 |
Why?
|
Optic Disk | 1 | 2016 | 421 | 0.390 |
Why?
|
Headache Disorders | 1 | 2014 | 152 | 0.390 |
Why?
|
Pons | 1 | 2012 | 240 | 0.380 |
Why?
|
Nervous System Malformations | 1 | 2012 | 244 | 0.360 |
Why?
|
Back Pain | 1 | 2014 | 545 | 0.360 |
Why?
|
Rotation | 1 | 2010 | 517 | 0.310 |
Why?
|
Nervous System Diseases | 1 | 2019 | 1666 | 0.300 |
Why?
|
Neurosurgical Procedures | 1 | 2018 | 2072 | 0.270 |
Why?
|
Pregnancy Complications | 1 | 2019 | 2947 | 0.240 |
Why?
|
Perception | 1 | 2010 | 1197 | 0.220 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2024 | 86 | 0.220 |
Why?
|
Machado-Joseph Disease | 1 | 2022 | 26 | 0.210 |
Why?
|
Glucagon-Like Peptides | 1 | 2024 | 153 | 0.210 |
Why?
|
Multiple Sclerosis | 1 | 2018 | 3224 | 0.210 |
Why?
|
Migraine Disorders | 1 | 2014 | 1700 | 0.190 |
Why?
|
Spinocerebellar Ataxias | 1 | 2022 | 105 | 0.190 |
Why?
|
Hemorrhage | 1 | 2012 | 3425 | 0.180 |
Why?
|
Leber Congenital Amaurosis | 1 | 2019 | 36 | 0.170 |
Why?
|
Optic Neuritis | 1 | 2021 | 174 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 36423 | 0.170 |
Why?
|
Optic Atrophy, Hereditary, Leber | 1 | 2019 | 50 | 0.170 |
Why?
|
Ophthalmoscopes | 1 | 2018 | 20 | 0.150 |
Why?
|
Neuromyelitis Optica | 1 | 2021 | 263 | 0.150 |
Why?
|
Ophthalmoscopy | 1 | 2016 | 171 | 0.130 |
Why?
|
Acetazolamide | 1 | 2014 | 96 | 0.120 |
Why?
|
Susac Syndrome | 1 | 2013 | 22 | 0.110 |
Why?
|
Furosemide | 1 | 2014 | 170 | 0.110 |
Why?
|
Cauda Equina | 1 | 2013 | 45 | 0.110 |
Why?
|
Brain | 2 | 2022 | 27107 | 0.110 |
Why?
|
Fructose | 1 | 2014 | 288 | 0.100 |
Why?
|
Retinal Diseases | 1 | 2018 | 704 | 0.100 |
Why?
|
Afferent Pathways | 1 | 2013 | 298 | 0.100 |
Why?
|
Tinnitus | 1 | 2014 | 196 | 0.100 |
Why?
|
Hypoglycemic Agents | 1 | 2024 | 3081 | 0.100 |
Why?
|
Visual Fields | 1 | 2018 | 1062 | 0.090 |
Why?
|
Diuretics | 1 | 2014 | 610 | 0.090 |
Why?
|
Stem Cell Transplantation | 1 | 2019 | 1600 | 0.090 |
Why?
|
Meningitis | 1 | 2012 | 217 | 0.090 |
Why?
|
Pituitary Neoplasms | 1 | 2018 | 1324 | 0.080 |
Why?
|
Psychophysics | 1 | 2010 | 292 | 0.080 |
Why?
|
Humans | 18 | 2024 | 761423 | 0.080 |
Why?
|
Sensory Thresholds | 1 | 2010 | 377 | 0.080 |
Why?
|
Physical Stimulation | 1 | 2010 | 517 | 0.080 |
Why?
|
Visual Pathways | 1 | 2013 | 551 | 0.080 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2013 | 710 | 0.070 |
Why?
|
Neuroprotective Agents | 1 | 2014 | 957 | 0.070 |
Why?
|
Adenoma | 1 | 2018 | 2160 | 0.070 |
Why?
|
Vestibular Diseases | 1 | 2010 | 230 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14664 | 0.070 |
Why?
|
Female | 9 | 2024 | 392581 | 0.070 |
Why?
|
Models, Psychological | 1 | 2010 | 828 | 0.060 |
Why?
|
Hearing Loss | 1 | 2010 | 783 | 0.050 |
Why?
|
Middle Aged | 6 | 2024 | 220826 | 0.050 |
Why?
|
Male | 7 | 2024 | 360736 | 0.050 |
Why?
|
Adult | 4 | 2019 | 221148 | 0.050 |
Why?
|
Psychometrics | 1 | 2010 | 3065 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4549 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12143 | 0.040 |
Why?
|
Transverse Sinuses | 1 | 2019 | 25 | 0.040 |
Why?
|
Adaptation, Psychological | 1 | 2010 | 2632 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 12970 | 0.040 |
Why?
|
Cranial Sinuses | 1 | 2019 | 68 | 0.040 |
Why?
|
Sclera | 1 | 2019 | 190 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 29620 | 0.040 |
Why?
|
Pregnancy | 1 | 2019 | 29862 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 8000 | 0.030 |
Why?
|
Pituitary Gland | 1 | 2019 | 635 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2019 | 1097 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2018 | 15650 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2016 | 39117 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2019 | 2927 | 0.030 |
Why?
|
Autoantibodies | 1 | 2021 | 2124 | 0.030 |
Why?
|
Retina | 1 | 2022 | 2658 | 0.020 |
Why?
|
Prospective Studies | 1 | 2016 | 54415 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2012 | 694 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2024 | 80582 | 0.020 |
Why?
|
Corpus Callosum | 1 | 2013 | 751 | 0.020 |
Why?
|
Adolescent | 2 | 2019 | 88313 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21341 | 0.020 |
Why?
|
Spinal Cord | 1 | 2013 | 1818 | 0.020 |
Why?
|
Young Adult | 1 | 2010 | 59207 | 0.010 |
Why?
|
Immunologic Factors | 1 | 2012 | 1588 | 0.010 |
Why?
|
Animals | 1 | 2013 | 168441 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8469 | 0.010 |
Why?
|
Risk Factors | 1 | 2024 | 74167 | 0.010 |
Why?
|
Aged | 1 | 2024 | 169235 | 0.010 |
Why?
|
Child | 1 | 2019 | 80162 | 0.010 |
Why?
|